Stocks Health care GTHP
OTC · Health careGuided Therapeutics Inc (GTHP)
Guided Therapeutics Inc brought in $650K of revenue over the twelve months to June 30, 2026, up 450.8% from a year earlier. It posted a net loss of $3.1M. In fiscal 2025 capital spending exceeded operating cash flow by $1.1M. At June 30, 2026 it held $12K in cash against $53K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Watch GTHP in 60 secondsWhat Guided Therapeutics Inc does
Guided Therapeutics Inc is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker GTHP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $767K | -$3.2M | -$0.04 | -$1.1M |
| 2024 | $7K | -$2.4M | -$0.05 | -$1.1M |
| 2023 | $98K | -$3.5M | -$0.07 | -$1.7M |
| 2022 | $13K | -$4.3M | -$0.15 | -$1.5M |
| 2021 | $81K | -$2.1M | -$0.18 | -$1.6M |
| 2020 | $102K | -$279K | -$0.04 | -$1.9M |
Full financial statements: income, balance sheet and cash flow
Where GTHP ranks in Health care
Latest SEC filings
What Guided Therapeutics Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026
- May 15, 2026
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue rose 10,857% to $767K versus the prior year; diluted EPS -$0.04 versus -$0.05.
- March 10, 2026
- November 13, 2025Quarterly report 10-Q · period to September 30, 2025Revenue was $60K; diluted EPS -$0.01 versus -$0.01.
- August 14, 2025
- May 15, 2025
- March 31, 2025Annual report 10-K · period to December 31, 2024Revenue fell 93% to $7K versus the prior year; diluted EPS -$0.05 versus -$0.07.
- December 23, 2024
- November 14, 2024Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running Guided Therapeutics Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| March 31, 2026 | Imhoff John EDirector, 10% owner | Exercised options | 157,417 | $11K |
| March 26, 2026 | Blumberg Richard P.Director, 10% owner | Other change | 56,093 | - |
| March 26, 2026 | Blumberg Richard P.Director, 10% owner | Other change | 260 | - |
| March 26, 2026 | Blumberg Richard P.Director, 10% owner | Other change | 1,040,000 | - |
| March 26, 2026 | Blumberg Richard P.Director, 10% owner | Other change | 19,038 | - |
| March 26, 2026 | Blumberg Richard P.Director, 10% owner | Other change | 88 | - |
| March 26, 2026 | Blumberg Richard P.Director, 10% owner | Other change | 352,000 | - |
| March 26, 2026 | Imhoff John EDirector, 10% owner | Other change | 2,157 | - |
| March 26, 2026 | Imhoff John EDirector, 10% owner | Other change | 10 | - |
| March 26, 2026 | Imhoff John EDirector, 10% owner | Other change | 40,000 | - |
| February 27, 2026 | Imhoff John EDirector, 10% owner | Other change | 100 | - |
| February 27, 2026 | Imhoff John EDirector, 10% owner | Other change | 400,000 | - |
| February 27, 2026 | Imhoff John EDirector, 10% owner | Exercised options | 156,086 | $10.9K |
| February 25, 2026 | Blumberg Richard P.Director, 10% owner | Exercised options | 1,000,000 | - |
| February 25, 2026 | Imhoff John EDirector, 10% owner | Exercised options | 500,000 | - |
Who owns GTHP
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
3 insiders reported holding 32,297,479 shares in total, about $5.8M at the last price.
| Holder | Shares |
|---|---|
| Imhoff John EDirector, 10% owner | 21,252,673 |
| Blumberg Richard P.Director, 10% owner | 10,391,311 |
| James Michael CDirector | 653,495 |
Questions about GTHP
What does Guided Therapeutics Inc do?
Guided Therapeutics Inc is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker GTHP.
Is Guided Therapeutics Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.1M on revenue of $650K.
How much revenue does Guided Therapeutics Inc make?
Over the twelve months to June 30, 2026 Guided Therapeutics Inc reported revenue of $650K. That is 450.8% more than a year earlier.
When did Guided Therapeutics Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.
Similar companies
Compare GTHP with
Follow GTHP
Get an email when Guided Therapeutics Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow GTHP: get an email when it filesWhere the numbers come from
Financial figures are the values Guided Therapeutics Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.